Philip Pape: 2:21 I want to give a special shout out to Michael Kay, one of our longtime listeners
Fortunately, medical providers offer innovative solutions designed to help you lose that stubborn weight for good
Safety profile in PIONEER trials: Nausea: 11% to 20% (dose-dependent) Diarrhea: 8% to 11% Vomiting: 5% to 9% Discontinuation due to GI side effects: 4% to 7% The side effect rates are lower than injectable semaglutide at weight-loss doses, likely because the systemic exposure is lower
This suggests that for retatrutide, the final maintenance dose may be more significant than the speed of reaching it
Apply heat to muscles that are tight or tense
Triozzi, M.D., an instructor in the Division of Nephrology and Hypertension and the studys first author, noted that these findings suggest GLP-1 receptor agonists could have broader kidney-protective effects that initially thought